BJS

BJS is the premier peer-reviewed surgical journal in Europe, with an Impact Factor of 8.8. #LeadingSurgicalEducation

[BJS @BJSurgery]

Saving the surgeon-scientist: need to build enduring support for surgical science
➡️https://t.co/w4zmuatpJM

🩺🔬 The surgeon-scientist is an endangered species

🪡This BJS Needlepoint article highlights the growing challenges facing surgeon-scientists worldwide—from inadequate salary support and limited protected research time to increasing clinical demands
Sustaining surgical innovation will require coordinated action from funding agencies, institutions, and health systems to protect the vital link between scientific discovery and patient care

Work by Noémie Villemure-Poliquin , Stephanie Wong , Julie Hallet

#SurgeonScientist #AcademicSurgery #SurgicalResearch #SurgicalInnovation #SoMe4Surgery #SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #some4hpb #some4tpl @DPCG_official @pancreatitis_nl @PancreasClub #PancreasClub2023 #PancreaticCancer #Pancreatitis #HCC @PanCAN #PanCANawareness @EurPancClub @P_C_E_ @dice_europe #PancreaticCancer #cholangiocarcinoma #HPBSurgery #GallbladderCancer #Oncology #LiverSurgery #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI #ERAS @dice_europe #Crohn #proctology @Dukes_Club @ACPGBI_EduTrain @AECP_FAECP @PelvExGroup @escp_tweets @YouESCP #TeachMeColoproctology
#Some4COLoprocto #some4UGI #uppergi #esophagealcancer #gastriccancer #reflux @ISDE_net @Augishealth @roux_group @T4UGIS @SARONG_Trial @YoungIFSO #bariatricsurgery

[BJS @BJSurgery]

Anastomotic leak after colorectal surgery: current landscape and future directions
➡️ https://t.co/JhVNo8RuJQ

🔗 Anastomotic leak remains one of the most feared complications after colorectal surgery, with major consequences including sepsis, reoperation, permanent stoma, and poorer oncological outcomes
📊 Leak rates remain substantial despite modern care: 3–6% after ileocolic anastomoses and up to 10–20% after low colorectal anastomoses
🧬 Anastomotic healing is multifactorial, involving surgical technique, perfusion, host immune response, and the gut microbiome
💡 ICG fluorescence angiography may improve perfusion assessment, particularly in rectal cancer surgery, but standardized quantitative thresholds are still needed
🦠 The microbiome is emerging as a key contributor, with collagenase-producing bacteria potentially weakening the anastomosis
🎯 Future prevention will likely require personalized risk stratification and targeted interventions rather than a one-size-fits-all approach

Work by Jack A Helliwell , Aaron Quyn , David G Jayne

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI #ERAS @dice_europe #Crohn #proctology @Dukes_Club @ACPGBI_EduTrain @AECP_FAECP @PelvExGroup @escp_tweets @YouESCP #TeachMeColoproctology
#Some4COLoprocto

[BJS @BJSurgery]

Incidence of autoimmune disease after hernia surgery with a mesh implant: national retrospective cohort study
➡️ https://t.co/jXxgWvhkoe

In a nationwide Dutch cohort, polypropylene mesh implantation was not associated with an increased medium-term risk of autoimmune disease
New autoimmune disease occurred at similar rates after mesh hernia repair and control surgery (1.1% vs 1.5%)

Work by Maurits J C A M Gielen , Ahmed M Chaoui , Samantha Schoenmakers , Bas Vreugdenhil , Tim Lubbers , Richard P G Ten Broek , Rudi M H Roumen , Nicole D Bouvy , Willem A R Zwaans

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide @eurohernias #hernia

[BJS @BJSurgery]

Development of a standard definition of ‘no-option’ and ‘poor-option’ for revascularization in chronic limb-threatening ischemia
➡️https://t.co/QWzz2BdHk3

🦵 How should we define “no-option” or “poor-option” CLTI?
🌍 This modified Delphi study brought together 164 vascular specialists from 30 countries to develop an expert-validated definition.
📊 Consensus supported a multidomain ABRFC framework: arterial anatomy, biology, risk, function, and context.
⚠️ “No-option” CLTI includes desert foot, prohibitive medical risk, non-functional limb, or patient refusal of revascularization.
🔍 “Poor-option” CLTI reflects combined factors such as severe infection, lack of autologous vein, or treatment non-compliance.
🎯 This framework can standardize clinical assessment, trial design, reporting, and future guideline development.

Work by Mario Alejandro Fabiani , Jos C van den Berg , Oscar A De la Torre , Alfredo Verastegui , Anahita Dua On Behalf of , the International Cooperative Vascular Consortium (ICVC)

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #vascularsurgery #vascular #Ischemia @vascularsurgery

[BJS @BJSurgery]

Presurgical levels of circulating tumour DNA in patients with resectable chemotherapy-naïve colorectal liver metastases: association with multiorgan recurrence and survival in the MIRACLE cohort
➡️ https://t.co/njD0HKrEah

📊 In this cohort of 182 patients undergoing curative-intent treatment for CRLM, 19% were classified as ctDNA-high using the mFast-SeqS aneuploidy assay.
⚠️ ctDNA-high patients had markedly worse outcomes, with 1-year recurrence-free survival of 29% vs 52% and 3-year overall survival of 48% vs 78%.
🌍 Multiorgan recurrence within the first year was significantly more common in ctDNA-high patients.
🔍 The aneuploidy score independently predicted recurrence and survival on multivariable analysis.
🎯 mFast-SeqS may provide a low-cost, minimally invasive strategy to identify patients at high risk of rapid recurrence before treatment.

Work by Lissa Wullaert , Lotte van Leeuwen , Vanja de Weerd , Mai Van , Esther Oomen-de Hoop , Jaco Kraan , Maurice P H M Jansen , John W M Martens , Dirk J Grünhagen , Henk M W Verheul , Cornelis Verhoef , Saskia M Wilting

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #some4hpb #some4tpl @DPCG_official @pancreatitis_nl @PancreasClub #PancreasClub2023 #PancreaticCancer #Pancreatitis #HCC @PanCAN #PanCANawareness @EurPancClub @P_C_E_ @dice_europe #PancreaticCancer #cholangiocarcinoma #HPBSurgery #GallbladderCancer #Oncology #LiverSurgery

[BJS @BJSurgery]

Surgical innovation and technology
➡️ https://t.co/dwlZC4QeDK

The future of surgery will be more precise, personalized, and technology-enabled—but innovation must be judged by its impact on patient care, not by novelty alone

This BJS Commission highlights how surgeons, engineers, scientists, and industry can work together to ensure new tools improve outcomes, equity, and value

Work by @JBMatthews, Jelle P Ruurda , Peter G Vaughan-Shaw , Desmond C Winter , Andrew Beggs , Andrew Yiu , Brian Davidson , Barbara Seeliger , Chen Xin , Daniel Stoyanov , Daphne D Rietbergen , Fijs W B van Leeuwen , Gerlof M Kuiper , Guglielmo N Piozzi , Jianing Qiu , James M Kinross , João Ramalhinho , Jim S Khan , Kurinchi Gurusamy , Kyle Lam , Kai F Chan , Li Zhang , Matthew Boal , Matthew J Clarkson , Matthias N van Oosterom , Nader Francis , Neeraj Lal , Philip W Y Chiu , Tessa Buckle , Yafit Shasha , Israa F E Hussein

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #some4hpb #some4tpl @DPCG_official @pancreatitis_nl @PancreasClub #PancreasClub2023 #PancreaticCancer #Pancreatitis #HCC @PanCAN #PanCANawareness @EurPancClub @P_C_E_ @dice_europe #PancreaticCancer #cholangiocarcinoma #HPBSurgery #GallbladderCancer #Oncology #LiverSurgery #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI #ERAS @dice_europe #Crohn #proctology @Dukes_Club @ACPGBI_EduTrain @AECP_FAECP @PelvExGroup @escp_tweets @YouESCP #TeachMeColoproctology #Some4COLoprocto #some4UGI #uppergi #esophagealcancer #gastriccancer #reflux @ISDE_net @Augishealth @roux_group @T4UGIS @SARONG_Trial @YoungIFSO #bariatricsurgery

[BJS @BJSurgery]

Surgical innovation and technology
➡️ https://t.co/dwlZC4QeDK

The future of surgery will be more precise, personalized, and technology-enabled—but innovation must be judged by its impact on patient care, not by novelty alone

This BJS Commission highlights how surgeons, engineers, scientists, and industry can work together to ensure new tools improve outcomes, equity, and value

Work by @JBMatthews, Jelle P Ruurda , Peter G Vaughan-Shaw , Desmond C Winter , Andrew Beggs , Andrew Yiu , Brian Davidson , Barbara Seeliger , Chen Xin , Daniel Stoyanov , Daphne D Rietbergen , Fijs W B van Leeuwen , Gerlof M Kuiper , Guglielmo N Piozzi , Jianing Qiu , James M Kinross , João Ramalhinho , Jim S Khan , Kurinchi Gurusamy , Kyle Lam , Kai F Chan , Li Zhang , Matthew Boal , Matthew J Clarkson , Matthias N van Oosterom , Nader Francis , Neeraj Lal , Philip W Y Chiu , Tessa Buckle , Yafit Shasha , Israa F E Hussein

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #some4hpb #some4tpl @DPCG_official @pancreatitis_nl @PancreasClub #PancreasClub2023 #PancreaticCancer #Pancreatitis #HCC @PanCAN #PanCANawareness @EurPancClub @P_C_E_ @dice_europe #PancreaticCancer #cholangiocarcinoma #HPBSurgery #GallbladderCancer #Oncology #LiverSurgery #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI #ERAS @dice_europe #Crohn #proctology @Dukes_Club @ACPGBI_EduTrain @AECP_FAECP @PelvExGroup @escp_tweets @YouESCP #TeachMeColoproctology #Some4COLoprocto #some4UGI #uppergi #esophagealcancer #gastriccancer #reflux @ISDE_net @Augishealth @roux_group @T4UGIS @SARONG_Trial @YoungIFSO #bariatricsurgery

[BJS @BJSurgery]

Surgical innovation and technology
➡️ https://t.co/dwlZC4QMti

The future of surgery will be more precise, personalized, and technology-enabled—but innovation must be judged by its impact on patient care, not by novelty alone

This BJS Commission highlights how surgeons, engineers, scientists, and industry can work together to ensure new tools improve outcomes, equity, and value

Work by @JBMatthews, Jelle P Ruurda , Peter G Vaughan-Shaw , Desmond C Winter , Andrew Beggs , Andrew Yiu , Brian Davidson , Barbara Seeliger , Chen Xin , Daniel Stoyanov , Daphne D Rietbergen , Fijs W B van Leeuwen , Gerlof M Kuiper , Guglielmo N Piozzi , Jianing Qiu , James M Kinross , João Ramalhinho , Jim S Khan , Kurinchi Gurusamy , Kyle Lam , Kai F Chan , Li Zhang , Matthew Boal , Matthew J Clarkson , Matthias N van Oosterom , Nader Francis , Neeraj Lal , Philip W Y Chiu , Tessa Buckle , Yafit Shasha , Israa F E Hussein

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #some4hpb #some4tpl @DPCG_official @pancreatitis_nl @PancreasClub #PancreasClub2023 #PancreaticCancer #Pancreatitis #HCC @PanCAN #PanCANawareness @EurPancClub @P_C_E_ @dice_europe #PancreaticCancer #cholangiocarcinoma #HPBSurgery #GallbladderCancer #Oncology #LiverSurgery #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI #ERAS @dice_europe #Crohn #proctology @Dukes_Club @ACPGBI_EduTrain @AECP_FAECP @PelvExGroup @escp_tweets @YouESCP #TeachMeColoproctology
#Some4COLoprocto #some4UGI #uppergi #esophagealcancer #gastriccancer #reflux @ISDE_net @Augishealth @roux_group @T4UGIS @SARONG_Trial @YoungIFSO #bariatricsurgery

[BJS @BJSurgery]

Standards for reporting research methods, interventions, and Outcomes in Surgical Prehabilitation studies (SOS-Prehab)
➡️https://t.co/Bpn7eS1imj

🏋️ Prehabilitation trials need clearer and more consistent reporting to improve reproducibility and clinical implementation.
🌍 SOS-Prehab was developed through a two-round Delphi process with 53 international experts across exercise, nutrition, psychology, and perioperative care.
📋 The final checklist includes 40 items: 16 essential and 24 important reporting elements.
🔍 Key domains include intervention components, delivery methods, adherence, participant characteristics, and outcome measures.
📊 Used alongside CONSORT, SOS-Prehab may improve transparency, comparability, and evidence synthesis in prehabilitation research.
🎯 Better reporting can help accelerate translation of prehabilitation into clinical practice and policy.

Work by Chelsia Gillis , Daniel I McIsaac , Daniel Santa Mina , Stéphanie Chevalier , Gabriele Baldini , Francesco Carli , Celena Scheede-Bergdahl , Linda Edgar , Vanessa Smrk , Leah Avery , Amal Bessissow , Miquel Coca Martinez , Robert Copeland , Susanne Oksbjerg Dalton , Gerad Danjoux , Linda Denehy , Dominique Engel , Chloe Grimmett , Michael P Grocott , Heather L Gill , Sandy Jack , Bente Thoft Jensen , Denny Levett , Graciela Martinez-Palli , Zoe Merchant , John Moore , Nicolò Pecorelli , Ian Randall , Bernhard Riedel , Geoff Schierbeck , Gerrit Slooter , Malcolm West , Julio F Fiore, Jr. , Collaborators

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #some4hpb #some4tpl @DPCG_official @pancreatitis_nl @PancreasClub #PancreasClub2023 #PancreaticCancer #Pancreatitis #HCC @PanCAN #PanCANawareness @EurPancClub @P_C_E_ @dice_europe #PancreaticCancer #cholangiocarcinoma #HPBSurgery #GallbladderCancer #Oncology #LiverSurgery #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI #ERAS @dice_europe #Crohn #proctology @Dukes_Club @ACPGBI_EduTrain @AECP_FAECP @PelvExGroup @escp_tweets @YouESCP #TeachMeColoproctology
#Some4COLoprocto #some4UGI #uppergi #esophagealcancer #gastriccancer #reflux @ISDE_net @Augishealth @roux_group @T4UGIS @SARONG_Trial @YoungIFSO #bariatricsurgery @asgbi @ASiTofficial @eurohernias @SEIQuirurgica @ESCP_tweets @YouESCP

[BJS Academy @BJSAcademy]

GLP-1 therapies, metabolic surgery, long-term obesity care — how should they work together?

Our IFSO – BJS Academy Virtual Journal Club tackles one of the biggest questions in bariatric surgery, discussing the new international consensus guideline published in BJS.

Missed it LIVE? The recording is now available.

🎥 Watch here:
https://t.co/J0j1dAcGcR

@IfsoSecretariat #bariatric #surgery @BJSurgery

[BJS @BJSurgery]

Clinical Outcomes Associated with Prior GLP-1 Exposure in Burned Patients
➡️https://t.co/4LVbnZd8X8

[BJS @BJSurgery]

Clinical Outcomes Associated with Prior GLP-1 Exposure in Burned Patients
➡️https://t.co/4LVbnZd8X8

💉 GLP-1 receptor agonists may offer benefits beyond glycaemic control in burn patients, with potential anti-inflammatory and immunomodulatory effects.
📊 In a large matched cohort (n=8,307 per group), prior GLP-1 use was associated with 54% lower mortality (OR 0.46; p<0.001).
🏥 Significant reductions were seen in ICU admission (−35%) and intubation (−62%), indicating lower critical care needs.
🦠 Infectious complications were also reduced, including sepsis (−32%), pneumonia (−24%), and MRSA (−27%), with less antibiotic use.
⚠️ A signal toward increased hypertrophic scarring (+27%) was observed at longer follow-up.
🎯 Prior GLP-1 exposure may improve burn outcomes, supporting further prospective studies to guide perioperative strategies.

Work by Adam Boukind, MSE , Aviral C Sharma, BS , Marco J Henriquez, MD , Saif Badran, MD, PhD

#Burns #CriticalCare #GLP1 #SurgicalOutcomes #Inflammation #PerioperativeCare #SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #SoMe4Trauma #emgensurg @WSESurgery @NELANews

[Pat Tejedor @TejedorPat]

Incredibly happy and proud to have received a grant from the @AECP_FAECP to launch our systematic review&amp;Delphi study on recurrent diverticulitis! 🎉
Huge thanks to our amazing trainees, Andrea Taricani and Joaquín Mascaró, for all their behind-the-scenes work
Let’s get started!

[BJS @BJSurgery]

Development of a standard definition of ‘no-option’ and ‘poor-option’ for revascularization in chronic limb-threatening ischemia
➡️ https://t.co/QWzz2BdHk3

This consensus study established a structured, expert-validated definition of no option or poor option for revascularisation of patients with CLTI
The multidomain ABRFC framework provides a foundation for standardized clinical assessment, trial design, and future guideline development

Work by Mario Alejandro Fabiani , Jos C van den Berg , Oscar A De la Torre , Alfredo Verastegui , Anahita Dua On Behalf of , the International Cooperative Vascular Consortium (ICVC)

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #vascularsurgery #vascular #Ischemia @vascularsurgery

[BJS @BJSurgery]

Diagnosis of inflammatory bowel disease after symptomatic faecalimmunochemical testing: population-based cohort study
➡️ https://t.co/SbEBqoP9SU

IBD is more common than CRC in patients aged <50 years referred on symptomatic FIT pathways using FIT ≥10 µg Hb/g
In a selected cohort of dual-tested patients, FCP results provided additional risk stratification
Incorporating routine FCP testing into symptomatic FIT pathways may better target further investigations.

Work by James C K Ng , Alastair J Morton , Colin J Crooks , Joe West , Matthew J Grainge , Timothy R Card , David J Humes

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI #ERAS @dice_europe #Crohn #proctology @Dukes_Club @ACPGBI_EduTrain @AECP_FAECP @PelvExGroup @escp_tweets @YouESCP #TeachMeColoproctology
#Some4COLoprocto

[BJS Academy @BJSAcademy]

👏 Next up for BJS LIVE @evanscolorectal, joint Editor-in-Chief @BJSurgery

@asgbi #asgbi2026

[BJS @BJSurgery]

Clinical and molecular landscape of surgically resected early onset pancreatic cancer
➡️ https://t.co/zSGHlqUyCm

EOPC is associated with a shorter time to recurrence and more aggressive, adverse molecular pathology.

Work by Stephan B Dreyer , Adam Bryce , Fieke Froeling , Shannon Jackson Australian Pancreatic Cancer Genome Initiative , Leonor Santana , Euan J Dickson , Maria Coats , Colin McKay , David Holroyd , Andrew V Biankin , Nigel B Jamieson , David K Chang

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #some4hpb #some4tpl @DPCG_official @pancreatitis_nl @PancreasClub #PancreasClub2023 #PancreaticCancer #Pancreatitis #HCC @PanCAN #PanCANawareness @EurPancClub @P_C_E_ @dice_europe #PancreaticCancer #cholangiocarcinoma #HPBSurgery #GallbladderCancer #Oncology #LiverSurgery

[BJS Academy @BJSAcademy]

🔍 Explore the latest surgical research with our updated BJS Journals pages on BJS Academy.

We now have dedicated pages for both BJS and BJS Open, featuring automatically updated tables of contents so you can easily browse the newest articles, reviews, and commentary as soon as they are published.

📖 Discover:
• The latest issues and articles
• World-leading surgical research
• Open access content from BJS Open
• Easy access to journal updates in one place

Explore now:
➡️ https://t.co/FppmQY5cto

#LeadingSurgicalEducation #SurgicalResearch #MedEd #Surgery #OpenAccess @bjsurgery @bjsopen

[BJS @BJSurgery]

Management of incidental gallbladder cancer in a nationwide CAPBIL study
➡️https://t.co/aNA5D1TVtJ

🟡 Incidental gallbladder cancer remains a challenging diagnosis, with 5-year DFS and OS of 41.5% and 45.1% in this UK multicentre cohort (n=285).
🔪 Patients undergoing liver resection had significantly improved outcomes, with median OS of 72 vs 26 months compared with no further surgery.
💊 Completion of adjuvant chemotherapy was also associated with better survival (OS 47 vs 26 months).
📊 Most resections involved segment 4B/5, highlighting current surgical practice patterns across UK centres.
⚠️ Advanced tumour stage (T3–T4) and nodal metastases independently predicted worse survival outcomes.
🎯 These findings reinforce the importance of aggressive multimodal management and careful pathological staging in incidental GBC.

Work by the UK HPB Research Collaborative Group, United Kingdom

#HPBSurgery #GallbladderCancer #Oncology #LiverSurgery #SurgicalOncology #SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #some4hpb #some4tpl @DPCG_official @pancreatitis_nl @PancreasClub #PancreasClub2023 #PancreaticCancer #Pancreatitis #HCC @PanCAN #PanCANawareness @EurPancClub @P_C_E_ @dice_europe #PancreaticCancer

[BJS @BJSurgery]

Clinical Outcomes Associated with Prior GLP-1 Exposure in Burned Patients
➡️https://t.co/4LVbnZd8X8

💉 GLP-1 receptor agonists may offer benefits beyond glycaemic control in burn patients, with potential anti-inflammatory and immunomodulatory effects.
📊 In a large matched cohort (n=8,307 per group), prior GLP-1 use was associated with 54% lower mortality (OR 0.46; p<0.001).
🏥 Significant reductions were seen in ICU admission (−35%) and intubation (−62%), indicating lower critical care needs.
🦠 Infectious complications were also reduced, including sepsis (−32%), pneumonia (−24%), and MRSA (−27%), with less antibiotic use.
⚠️ A signal toward increased hypertrophic scarring (+27%) was observed at longer follow-up.
🎯 Prior GLP-1 exposure may improve burn outcomes, supporting further prospective studies to guide perioperative strategies.

Work by Adam Boukind, MSE , Aviral C Sharma, BS , Marco J Henriquez, MD , Saif Badran, MD, PhD

#Burns #CriticalCare #GLP1 #SurgicalOutcomes #Inflammation #PerioperativeCare #SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #SoMe4Trauma #emgensurg @WSESurgery @NELANews

[Malin Sund @MalinASund]

@BJSurgery The key is that in this randomized dataset BC specific survival outcomes are in line with earlier RCTs and show that these are eqiuvalent in terms of BC survival. Breast conservation has many of benefits overall, but better survival is not one of them.